investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Elucidating the role of new RasGAP tumor suppressors in cancer
Karen M Cichowski
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Karen M Cichowski
Brigham and Women's Hospital
Boston, United States
Related projects
Global Noncommunicable Diseases Intiatives
The Project for the Procurement of Mobile Mammography Clinic
Breast
Global Noncommunicable Diseases Intiatives
The project for breast cancer diagnosis and early detection
Breast
Suzanne A Fuqua
Integration of Predictive Biomarkers of Hormone Resistance in Breast Cancer
Breast
Global Noncommunicable Diseases Intiatives
Bus-Race for Cure
Breast
Christopher A Haiman
Genome-Wide Association Study of Breast Cancer in High-Risk Women
Breast
Paul A Dayton
Academic-Industrial Partnership for Translation of Acoustic Angiography
Breast
Global Noncommunicable Diseases Intiatives
Developing a National Clinical Breast Examination Certification Program for registered nurses
Breast
Ajit P Varki
Oligosaccharies of Normal and Malignant Cells
Breast
Ricardo Alvarez
Pilot Study of Prognostic Utility of Circulating Tumor Cells (CTCs) Assed by Adnagen Technology and Clinical Outcome of Patients with Stage II Breast Cancer who Completed Locoregional and Systematic Treatment
Breast